# Eligo Bioscience S.A.S

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eligo-bioscience-s-a-s

- Industry: Biotechnology
- Headquarters: Paris, France
- Website: www.eligo.bio
- Total disclosed funding: $45M
- Latest round: Series B (Dec 2, 2023)
- Investors on record: 4

## About

Founded in 2014 and based in Paris, France, Eligo Bioscience S.A.S operates as a biotechnology platform that develops antibiotics for bacteria-associated diseases and precision microbiome engineering.

## Funding rounds

- Series B, Dec 2, 2023, $30M — Seventure Partners, Khosla Ventures, Sanofi Ventures, Bpifrance Investissement
- Series B, Feb 25, 2020, $9.6M — Seventure Partners, Khosla Ventures
- Series B, Sep 26, 2017, $5.8M — Seventure Partners, Khosla Ventures

## Investors

- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series B
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series B
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series B
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series B